| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Hyperlipoproteinemia Type II | D006938 | 22 associated lipids |
| Hyperemia | D006940 | 25 associated lipids |
| Hyperlipidemias | D006949 | 73 associated lipids |
| Hyperlipoproteinemias | D006951 | 15 associated lipids |
| Hyperlipoproteinemia Type IV | D006953 | 6 associated lipids |
| Hypersensitivity | D006967 | 22 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Hypertension, Portal | D006975 | 12 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Hypertension, Renal | D006977 | 9 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Hypolipoproteinemias | D007009 | 9 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Erectile Dysfunction | D007172 | 19 associated lipids |
| Infant, Premature, Diseases | D007235 | 7 associated lipids |
| Infertility | D007246 | 3 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Power I et al. | Effects of ketorolac and dextran-70 alone and in combination on haemostasis. | 1998 | Acta Anaesthesiol Scand | pmid:9773144 |
| Liou JT et al. | Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner. | 2012 | Acta Anaesthesiol Taiwan | pmid:23026170 |
| Jécsai G and Bagdány S | Quantitative determination of thromboxane synthesis in blood samples by video-densitometry. | 1980 | Acta Biochim. Biophys. Acad. Sci. Hung. | pmid:7282294 |
| Sochanowicz B et al. | Increased thromboxane production after whole body irradiation. | 1990 | Acta Biochim. Pol. | pmid:2087899 |
| Sochanowicz B and Dancewicz AM | Thromboxane increase in irradiated animals is caused by stimulation of cyclooxygenase activity. | 1992 | Acta Biochim. Pol. | pmid:1485488 |
| Vila L et al. | Exogenous arachidonic acid metabolism in platelets from psoriatic patients. | 1990 | Acta Derm. Venereol. | pmid:1969193 |
| Gragnoli G et al. | Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes. | 1985 | Acta Endocrinol. | pmid:2408435 |
| Gréen K et al. | Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus. | 1988 | Acta Endocrinol. | pmid:3291538 |
| Peskar BM | Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system. | 1983 Sep-Oct | Acta Gastroenterol. Belg. | pmid:6324520 |
| Luzzatto G et al. | Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis. | 1987 | Acta Haematol. | pmid:2955629 |